Lawyer profile
Michael Sweeney
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- corporate and collaboration matters, debt facility, IP
- Office
- Los Angeles
- Active in the record
- 2021 to 2024
Deal experience
Deals
7 announced deals in the record Latham & Watkins Advises Sanofi on Co-Exclusive Licensing Agreement With Novavax 23 May 2024
Latham & Watkins Advises Sanofi on Collaboration With Formation Bio and OpenAI 23 May 2024
Latham & Watkins Advises Verona Pharma in US$650 Million Strategic Financing, One of the Largest Life Sciences Financings of 2024 16 May 2024
Latham & Watkins Advises Icosavax in US$1.1 Billion Acquisition by AstraZeneca 13 Dec 2023
Latham & Watkins Advises on Vaxcyte US$500 Million Public Offering 20 Apr 2023
Latham & Watkins Advises Orbital Therapeutics in Strategic Partnership With Beam Therapeutics and Initial Funding 27 Oct 2022
Latham & Watkins Advises Obagi on US$1.2 Billion Business Combination with Waldencast and Milk Makeup as a First Step in Waldencast’s Strategy to Create a Global Multi-Brand Beauty and Wellness Platform 15 Nov 2021
Deal alerts PRO
Get an email when Michael Sweeney is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile